[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354767-105":59,"doc-detail-354767-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","lncrna-rams11-dependent-notch3-activation-drives-tumor-progression-in-non-small-cell-lung-cancer","LncRNA RAMS11-dependent NOTCH3 activation drives tumor progression in non-small cell lung cancer","","Lung cancer remains the leading cause of cancer-related death, and most cases are non-small cell lung cancer (NSCLC) diagnosed with metastasis or advanced disease. This study identifies the long noncoding RNA RAMS11 (LINC01564) as markedly upregulated in lung cancer patients. RAMS11 promotes NSCLC tumor progression by regulating NOTCH3 expression, requiring NRF2 chromatin binding and H3K27ac deposition at the NOTCH3 enhancer. RAMS11 disruption suppresses tumor growth and increases sensitivity to cisplatin-induced apoptosis, indicating a therapeutic vulnerability.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/lncrna-rams11-dependent-notch3-activation-drives-tumor-progression-in-non-small-cell-lung-cancer/354767/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/lncrna-rams11-dependent-notch3-activation-drives-tumor-progression-in-non-small-cell-lung-cancer/354767.png","ImageObject",300,407,{"name":92,"@type":93},"acoobca","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-16","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What role does RAMS11 play in NSCLC progression?","Question",{"text":113,"@type":114},"RAMS11 is significantly upregulated in lung cancer and is critical for NSCLC tumor progression. It drives malignant proliferation by activating NOTCH3 signaling.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does RAMS11 regulate NOTCH3 at the molecular level?",{"text":118,"@type":114},"RAMS11 is essential for NRF2 chromatin binding and promotes deposition of the active enhancer mark H3K27ac at the NOTCH3 enhancer. This supports RAMS11–NRF2 dependent NOTCH3 activation.",{"name":120,"@type":111,"acceptedAnswer":121},"Does targeting RAMS11 affect chemotherapy response?",{"text":122,"@type":114},"Disrupting RAMS11 signaling markedly suppresses tumorigenic growth and sensitizes NSCLC cells to cisplatin-induced apoptosis. This suggests RAMS11 as a potential therapeutic vulnerability.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},354767,1790167686,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":14,"preview_urls":147},3985747870733,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","NAR Cancer, 2026, 8, zcag020  \n[https://doi.org/10.1093/narcan/zcag020](https://doi.org/10.1093/narcan/zcag020)  \n[Cancer-specific RNAs and RNA Processing](Cancer-specific RNAs and RNA Processing)  \nLncRNA RAMS11-dependent NOTCH3 activation drives tumor progression in non-small cell lung cancer  \nGejae G. Jeffers1 , Yesol Kim1,2 , Nicole M. White1,2 , Li Lin1 , Emily B. Rozycki1 , Amy Ly1 , Christopher A. Maher 1,2,3 ,*  \n1 Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, 63110, United States  \n2Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, 63110, United States  \n3 Department of Biomedical Engineering, Washington University School of Medicine, St. Louis, MO, 63110, United States  \n∗ To whom correspondence should be addressed. Email: [christophermaher@wustl.edu](christophermaher@wustl.edu)  \nAbstract  \nLung cancer is currently the leading cause of cancer-related deaths worldwide. Approximately 85% of lung cancer patients have non-small cell lung cancer (NSCLC), and >50% of these patients present with metastasis at their initial diagnosis. Despite advances in our understanding of lung cancer oncogenesis, the mechanism by which lung cancer becomes aggressive and leads to patient death is still poorly characterized. We found that long noncoding RNA RNA-associated with metastasis 11 ( RAMS11) ( LINC01564) is significantly upregulated in lung cancer patients compared to healthy patients. Here, we demonstrate that RAMS11 is critical for NSCLC tumor progression by regulating expression of NOTCH3, a key driver of tumorigenic potential. Mechanistically, RAMS11 is essential for NRF2 chromatin binding and the associated deposition of the active enhancer mark, H3K27ac, at the NOTCH3 enhancer region. Functional analysis revealed RAMS11–NRF2-dependent activation of NOTCH3 signaling enforces a tumor-initiating capacity, characterized by enhanced self-renewal capabilities and tumor initiation ability, thereby supporting malignant proliferation. Moreover, disruption of RAMS11 signaling markedly suppressed tumorigenic growth and sensitized NSCLC cells tocisplatin-induced apoptosis, uncovering a potential therapeutic vulnerability to more effectively target NSCLC patients. Collectively, these findings reveal a previously unknown role of RAMS11 in NSCLC progression and chemotherapy resistance.  \nGraphical abstract  \nIntroduction  \nLung cancer is currently the leading cause of cancer-related deaths, and it is the second most common cancer in the USA [1]. Non-small cell lung cancer (NSCLC) accounts for ∼85% of all lung cancer cases [2]. NSCLC patients have no typical or noticeable clinical symptoms in the early stages; thus >60% of patients are diagnosed with advanced-stage lung cancer at their initial diagnosis [3], resulting in a 5-year survival rate of \u003C10%[4] . This presents a critical need for understanding the mechanisms by which lung cancer becomes aggressive, which  \nin turn could lead to improved treatment options to increase patient survival rates.  \nLong noncoding RNAs (lncRNAs) are RNA molecules longer than 200 nt that are not translated [5, 6]. Emerging evidence shows that lncRNAs are frequently dysregulated in human cancers [7, 8] and are implicated in multiple cancer processes, including cell growth, apoptosis, drug resistance, and tumor metastasis [9–11]. In the context of lung cancer, our lab discovered 111 Lung Cancer Associated LncRNAs (LCALs) differentially expressed in transcriptome sequencing (RNA-  \nReceived: February 25, 2026. Revised: July 4, 2026. Accepted: July 26, 2026  \n© The Author(s) 2026 . Published by Oxford University Press.  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License  \n([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)), which permits non-commercial re-use, distribution, and reproduction in any medium, provided","cbCaijYfe0xDrg0N","https://ap.wps.com/l/cbCaijYfe0xDrg0N","pdf",4963489,14,"English","# Abstract\n# Introduction\n## Lung cancer burden and need for mechanism-based therapy\n## Role of long noncoding RNAs in cancer progression\n## Discovery context for RAMS11 and related lncRNAs","[{\"question\":\"What role does RAMS11 play in NSCLC progression?\",\"answer\":\"RAMS11 is significantly upregulated in lung cancer and is critical for NSCLC tumor progression. It drives malignant proliferation by activating NOTCH3 signaling.\"},{\"question\":\"How does RAMS11 regulate NOTCH3 at the molecular level?\",\"answer\":\"RAMS11 is essential for NRF2 chromatin binding and promotes deposition of the active enhancer mark H3K27ac at the NOTCH3 enhancer. This supports RAMS11–NRF2 dependent NOTCH3 activation.\"},{\"question\":\"Does targeting RAMS11 affect chemotherapy response?\",\"answer\":\"Disrupting RAMS11 signaling markedly suppresses tumorigenic growth and sensitizes NSCLC cells to cisplatin-induced apoptosis. This suggests RAMS11 as a potential therapeutic vulnerability.\"}]","LncRNA RAMS11-dependent NOTCH3 activation drives tumor progression in non-small cell lung cancer | PDF",1790113610,35,[148,152],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/02e5b184e85616140c166b1d6ad2745d.webp",983,1272,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/7a98051d45512d0319fd9c6140f4a738.webp",982,1270]